RL
PGEN icon

RPO LLC’s Precigen PGEN Stock Holding History

RPO LLC’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-42,143
Closed -$47.2K – 80
2024
Q4 		$47.2K Buy
+42,143
New +$35.9K 0.04% 62

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

RPO LLC's PGEN Position: Q1 2025 in Review

RPO LLC sold out of Precigen (PGEN) in Q1 2025, closing a stake of 42,143 shares — an estimated $47.2K sold.

RPO LLC first reported a position in PGEN in Q4 2024 and held it in 1 quarter. The position peaked at $47.2K in Q4 2024. 138 funds tracked by Wall St. Rank hold PGEN as of Q1 2025.

  • RPO LLC reported no remaining Precigen position as of Q1 2025 after selling out during the quarter.
  • RPO LLC sold 42,143 Precigen shares in Q1 2025, an estimated $47.2K.
  • RPO LLC first reported a position in Precigen in Q4 2024 and held it in 1 quarter.
  • RPO LLC's Precigen position peaked at $47.2K in Q4 2024.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q1 2025.

Based on RPO LLC's 13F filing for Q1 2025, filed 13 May 2025.